<PAGE>
1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 17, 2000
MEDICAL TECHNOLOGY SYSTEMS, INC.
--------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-16594 59-2740462
---------------------------- ------------------------ --------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
12920 Automobile Boulevard, Clearwater, Florida 33762
-----------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (727) 576-6311
---------------
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
2
This document and the accompanying exhibit contain statements that
constitute "forward-looking statements" within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities and
Exchange Act of 1934, as amended. The words "believe", "estimate", "expect",
"intend", "anticipate" and similar expressions and variations thereof identify
certain of such forward-looking statements, which speak only as of the dates on
which they were made. The Company undertakes no obligation to publicly update or
revise any forward-looking statements, whether as a result of new information,
future events or otherwise. Readers are cautioned that any such forward-looking
statements are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from those
indicated in the forward-looking statements as a result of various factors.
Readers are cautioned not to place undue reliance on these forward-looking
statements.
Item 5. Other Events
A total of 1,320,000 warrants (the "warrants") each of which was
exercisable to purchase one share of the Medical Technology Systems, Inc. (the
"Company") Common Stock for $7.00 expired today.
Item 7. Financial Statements and Exhibits
(c)Exhibits.
NONE
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: July 17, 2000
MEDICAL TECHNOLOGY SYSTEMS, INC.
(Registrant)
By: /s/ Michael P. Conroy
----------------------------------------------
Michael P. Conroy
Vice President and Chief Financial Officer
